Notably, the analysis revealed a significant upregulation of SLC16A1 in 12 different malignancies, indicating its potential involvement in tumorigenesis and suggesting a broader role across various cancer types (Fig. S4A). This evidence concerns the gene SLC16A1 and cancer.